Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for ovarian cancer.

K K Chan1, T J Selman

  • 1Birmingham Women's Hospital, Edgbaston, Birmingham B15 2TT, UK. charlie.chan@bwhct.nhs.uk

Best Practice & Research. Clinical Obstetrics & Gynaecology
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of traumatic uterine avulsion in pregnancy.

Trauma case reports·2023
Same author

Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.

Annals of surgical oncology·2022
Same author

Telemedicine in COVID-19 pandemic: Anaesthetic assessment of elective surgical patients through mobile application-based questionnaire.

Indian journal of anaesthesia·2022
Same author

Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension.

Hong Kong medical journal = Xianggang yi xue za zhi·2020
Same author

Novel SLOFT technique.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
Same author

A prospective evaluation of the outcome of submucosal ligation of fistula tract.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020

Ovarian cancer causes more deaths than cervical and endometrial cancers combined. Early detection is challenging due to non-specific symptoms, necessitating improved screening and diagnostic methods for high-risk individuals.

Area of Science:

  • Oncology
  • Gynecologic Oncology
  • Medical Diagnostics

Background:

  • Ovarian cancer is a leading cause of gynecologic cancer deaths, exceeding combined mortality from cervical and endometrial cancers.
  • Late-stage diagnosis is common due to vague, non-specific symptoms, complicating early intervention.
  • Distinguishing benign from malignant ovarian masses is clinically challenging.

Purpose of the Study:

  • To review current diagnostic and screening approaches for ovarian cancer.
  • To highlight the limitations of existing methods and the need for improved early detection strategies.
  • To discuss the potential of emerging technologies in ovarian cancer diagnostics.

Main Methods:

  • Review of existing literature on ovarian cancer screening and diagnostics.

Related Experiment Videos

  • Assessment of the accuracy of current screening tools, including CA125 and ultrasound.
  • Exploration of novel proteomic technologies for early cancer detection.

    • Main Results:

    • Current screening methods like CA125 and ultrasound are under evaluation for accuracy in randomized controlled trials.
    • Proteomic technology demonstrates potential for early ovarian cancer detection.
    • The lack of accurate early diagnostic techniques currently leads high-risk patients to opt for prophylactic surgery.

    Conclusions:

    • There is a critical need for improved screening and early diagnostic techniques for ovarian cancer.
    • Emerging technologies, such as proteomics, offer promising avenues for earlier and more accurate detection.
    • Advancements in diagnostics are essential to reduce mortality and potentially decrease the reliance on prophylactic surgeries for high-risk patients.